<DOC>
	<DOCNO>NCT00005035</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness oxaliplatin treat patient advanced head neck cancer .</brief_summary>
	<brief_title>Oxaliplatin Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate patient advance squamous cell carcinoma head neck treat oxaliplatin . II . Characterize toxicity pharmacokinetics drug patient population . III . Determine duration response , time progression , survival patient receive drug . OUTLINE : Patients stratify accord prior treatment neoadjuvant chemotherapy ( yes v ) . Patients receive oxaliplatin IV 2 hour weekly 4 week follow 2 week rest . Treatment continue every 6 week absence unacceptable toxicity disease progression . Patients follow toxicity resolve le 30 day . PROJECTED ACCRUAL : A total 34-74 patient accrue study within 17 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm squamous cell carcinoma head neck Recurrent metastatic OR Locally advance judge incurable surgery radiotherapy Bidimensionally measurable disease New unirradiated lesion within prior radiation field acceptable measurable disease least 3 month since prior radiotherapy No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 OR Karnofsky 50100 % Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin normal AST/ALT great 2.5 time upper limit normal Renal : Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular : No symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No evidence neuropathy No history allergy platinum compound antiemetic appropriate administration conjunction protocol therapy No concurrent uncontrolled illness ( e.g. , ongoing active infection ) Not HIV positive AND receive antiretroviral therapy ( HAART ) PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy head neck cancer No concurrent colony stimulate factor first course therapy Chemotherapy : No prior chemotherapy recurrent metastatic disease At least 3 month since prior chemotherapy initial treatment Endocrine therapy : No prior hormonal therapy head neck cancer Radiotherapy : See Disease Characteristics At least 3 month since prior radiotherapy initial treatment Surgery : See Disease Characteristics Prior surgery allow Other : No concurrent investigational commercial agent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2002</verification_date>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>